PROtrol SARS-CoV-2 Lineage B.1.617.2; Delta Variant (Isolate: USA/PHC658/2021)

SARS-Related Coronavirus 2 Lineage B.1.617.2; Delta Variant (Isolate: USA/PHC658/2021) is an enveloped, positive-sense single-stranded RNA virus from the Coronaviridae family and the Betacoronaviridae genus. Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), isolate hCoV-19/USA/PHC658/2021 was isolated in Memphis, Tennessee, USA in May 2021. Under the nomenclature system introduced by GISAID (Global Initiative on Sharing All Influenza Data), SARS-CoV-2, isolate hCoV-19/USA/PHC658/2021 is assigned lineage B.1.617.2 using Phylogenetic Assignment of Named Global Outbreak LINeages (PANGOLIN) tool. SARS CoV-2, lineage B.1.617.2 was first detected in India and labelled as a variant of concern (VOC). It was labelled as Delta variant by the World Health Organization (WHO).

SARS-CoV-2 was propagated in VeroE6 cells. The viral culture fluid was clarified via centrifugation to remove cellular debris prior to inactivation.

PROtrol (Protein control) is formulated with viral particles that have been modified to render them non-infectious. Each vial contains 1.0 mL of SARSCoV-2 PROtrol frozen in 2% MEM media.

PROtrol is intended for use in analytical and quality control testing of antigen-based assays. The suitability and performance characteristics should be determined by your laboratory for each intended usage.
These products are NOT intended for use in the manufacture or processing of injectable products subject to licensure under section 351 of the Public Health Service Act or for any other product intended for administration to humans.

To be stored at -65° C. / -20° C.
Product Insert.pdf

Material Safety Data Sheet.pdf